enzyme mimic
Recently Published Documents


TOTAL DOCUMENTS

127
(FIVE YEARS 46)

H-INDEX

28
(FIVE YEARS 6)

Nano Research ◽  
2021 ◽  
Author(s):  
Chang Long ◽  
Kaiwei Wan ◽  
Xueying Qiu ◽  
Xiaofei Zhang ◽  
Jianyu Han ◽  
...  
Keyword(s):  

2021 ◽  
Author(s):  
Xiaomin Qian ◽  
Isabella Nymann Westensee ◽  
Catarina Cavalheiro Fernandes ◽  
Brigitte Städler

Author(s):  
Xiaomin Qian ◽  
Isabella Nymann Westensee ◽  
Catarina Cavalheiro Fernandes ◽  
Brigitte Städler

APL Materials ◽  
2021 ◽  
Vol 9 (5) ◽  
pp. 051110
Author(s):  
Phouphien Keoingthong ◽  
Shengkai Li ◽  
Zhaotian Zhu ◽  
Liang Zhang ◽  
Jieqiong Xu ◽  
...  
Keyword(s):  

2021 ◽  
Vol 9 (2) ◽  
pp. 105044
Author(s):  
Laila Al-Alharbi ◽  
Arwa Alrooqi ◽  
Mohamed M. Ibrahim ◽  
Ibrahim M. El-Mehasseb ◽  
Tushar Kumeria ◽  
...  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Ping Zhu ◽  
Zhihui Xu ◽  
Ling Cai ◽  
Jin Chen

AbstractPorphyrin iron molecules (hemin) were successfully grafted on the channeled mesoporous silica of SBA-15 (FeIX-SBA-15), in which attached hemin molecules acted as the enzyme mimic for catalyzing oxidation reactions. In the presence of H2O2, the prepared FeIX-SBA-15 composite effectively degraded industrial dye Orange II and catalyzed tetramethylbenzidine hydrochloride (TMB) both in the solution and on the membrane, from which the colorimetric H2O2 detection was achieved. Moreover, the hemin-grafted composites showed high loading content of anticancer drug of doxorubicin hydrochloride (DOX) displaying the sustained releasing behavior as monitored by real-time cell analysis, which resulted in improved inhibitory effect on cancer cells growth compared with that DOX/SBA-15. The hemin-modified mesoporous silica nanocomposite provides an integrated nanoplatform with promising biomedical applications.


Sign in / Sign up

Export Citation Format

Share Document